1
Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Condition(s):Hypertriglyceridemia; Metabolic SyndromeLast Updated:December 15, 2021Completed
Fenoglide: 241 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Effects of Fenofibrate Therapy in Diabetic Nephropathy
Condition(s):Diabetes Mellitus; Diabetic NephropathiesLast Updated:December 14, 2020Recruiting
3
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Terminated
4
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
Condition(s):MicroalbuminuriaLast Updated:December 11, 2014Unknown status
5
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors – Effect of Fenofibrate
Condition(s):Covid19Last Updated:October 15, 2021Recruiting
6
Fenofibrate in Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type IILast Updated:February 8, 2022Completed
7
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
Condition(s):HypertensionLast Updated:June 28, 2013Completed
8
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
Condition(s):Primary Biliary CirrhosisLast Updated:September 17, 2021Withdrawn
9
Evaluation of Fenofibrate on Radiation-induced Skin Injury
Condition(s):RadiodermatitisLast Updated:June 15, 2018Unknown status
10
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
Condition(s):HypertriglyceridemiaLast Updated:December 14, 2009Completed